CLNN Insider Trading (Clene)
Insider Ownership Percentage: 21.20%
Insider Buying (Last 12 Months): $1,999,996.92
Insider Selling (Last 12 Months): $0.00
Clene Insider Trading History Chart
Clene Share Price & Price History
As of 06/22/2021 02:47 PM ET
Peter Thiel Bets Big On "Mushroom Boom."
LSD and "Mushroom stocks" are being listed on the NASDAQ and a recent breakthrough makes top investors VERY excited about the coming "Mushroom Boom."
Click Here To Read The Full Story
Clene Insider Trading History
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|5/24/2021||David J. Matlin||Director||Buy||207,684||$9.63||$1,999,996.92||32,393|| |
SEC Filings (Institutional Ownership Changes) for Clene (NASDAQ:CLNN)
4.15% of Clene stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.
Institutional Buying and Selling by Quarter
Clene Institutional Trading History
Data available starting January 2016
|Reporting Date||Hedge Fund||Shares Held||Market Value||% of Portfolio||Quarterly Change in Shares||Ownership in Company||Details|
|5/19/2021||Squarepoint Ops LLC||30,676||$0.39M||0.0%||N/A||0.051%|
|5/18/2021||Millennium Management LLC||130,068||$1.66M||0.0%||N/A||0.218%|
|5/18/2021||Citadel Advisors LLC||46,163||$0.59M||0.0%||N/A||0.077%|
|5/17/2021||Ikarian Capital LLC||118,533||$1.52M||0.1%||N/A||0.199%|
|5/17/2021||Goldman Sachs Group Inc.||13,593||$0.17M||0.0%||N/A||0.023%|
|5/13/2021||Laird Norton Trust Company LLC||249,561||$3.19M||0.4%||N/A||0.419%|
|5/13/2021||Penserra Capital Management LLC||5,840||$74K||0.0%||N/A||0.010%|
|5/13/2021||Kepos Capital LP||200,000||$2.56M||0.2%||-24.0%||0.336%|
|5/12/2021||Northern Trust Corp||40,246||$0.51M||0.0%||N/A||0.068%|
|5/12/2021||Geode Capital Management LLC||220,355||$2.82M||0.0%||N/A||0.370%|
|4/27/2021||Harel Insurance Investments & Financial Services Ltd.||34,911||$1.49M||0.0%||N/A||1.010%|
|2/16/2021||Walleye Trading LLC||15,909||$0.14M||0.0%||N/A||0.460%|
|2/12/2021||Basso Capital Management L.P.||3,239||$29K||0.0%||N/A||0.094%|
|2/12/2021||Kepos Capital LP||263,235||$2.37M||0.2%||N/A||7.617%|
|2/10/2021||Bluefin Capital Management LLC||15,378||$0.14M||0.0%||N/A||0.445%|
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean surfaced nanotechnology (CSN) therapeutics. The company has a nanotechnology drug suspension; and engages in the development and commercialization of dietary supplements. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2 study for the treatment of stable multiple sclerosis; a Phase 2 biomarker study in Parkinson's; and Phase 2 and Phase 3 trials to investigate the potential for disease modification for neurodegenerative diseases. The company's products also include CNM-AgZn17, a topical gel polymer suspension of silver and zinc ions that is being developed for the treatment of infectious diseases and to accelerate wound healing; CNM-ZnAg, a broad-spectrum antiviral and antibacterial agent to treat disease-causing infections, such as COVID-19 and to provide immune support for symptom resolution; and CNM-PtAu7, a gold-platinum CSN therapeutic for oncology applications. Clene Inc. is headquartered in Salt Lake City, Utah.
50 Day Range
52 Week Range
Who are the company insiders with the largest holdings of Clene?
Clene's top insider shareholders include:
- David J Matlin (Director)
Who are the major institutional investors of Clene?
Clene's top institutional shareholders include:
- Laird Norton Trust Company LLC — 0.42%
- Geode Capital Management LLC — 0.37%
- Kepos Capital LP — 0.34%
- Millennium Management LLC — 0.22%
- Ikarian Capital LLC — 0.20%
- BlackRock Inc. — 0.09%
Which institutional investors are selling Clene stock?
Within the last quarter, CLNN stock was sold by these institutional investors:
- Kepos Capital LP
Which institutional investors are buying Clene stock?
During the last quarter, CLNN stock was acquired by institutional investors including:
- Laird Norton Trust Company LLC
- Geode Capital Management LLC
- Millennium Management LLC
- Ikarian Capital LLC
- BlackRock Inc.
- Citadel Advisors LLC
- Northern Trust Corp
- Harel Insurance Investments & Financial Services Ltd.